ProfileGDS4177 / 220602_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 71% 74% 74% 71% 80% 76% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated101.4771
GSM603099KU-812 non-treated136.5474
GSM603098KCL-22 Imatinib-treated138.3874
GSM603097KCL-22 non-treated112.1971
GSM603102JURL-MK1 Imatinib-treated214.3880
GSM603101JURL-MK1 non-treated151.8376